Close

Wells Fargo Downgrades NxStage Medical (NXTM) to Underperform

March 11, 2014 8:05 AM EDT Send to a Friend
Wells Fargo downgraded NxStage Medical (NASDAQ: NXTM) from Market Perform to Underperform with a price target of $10-$12 (from $11-$14).
This article: 195 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login